Formulation, Characterization, and Stability of Protein Drugs

A Compendium and Hydropathy/Flexibility Analysis of Common Reactive Sites in Proteins: Reactivity at Asn, Asp, Gin and Met Motifs in Neutral pH Solution, M. Powell. Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor, Y.J. Wang, et al. The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor, D.B. Volkin, C.R. Middaugh. Stability, Characterization, Formulation, and Delivery System Development for Transforming Growth Factor-Beta 1 , W.R. Gombotz, et al. Stability and Characterization of Recombinant Human Relaxin, T.H. Nguyen, S.J. Shire. Interferon- Pds. I i Pds. -1b (Betaserson): A Model for Hydrophobic Therapeutic Proteins, L.S. Lin, et al. Characterization, Formulation, and Stability of Neupogen (Filgrastim): A Recombinant Human Granulocyte Colony Stimulating Factor, A.C. Herman, et al. Development and Shelflife Determination of Recombinant Human Granulocytemacrophage Colonystimulating Factor (Leukin, GMCSF), J. Geigert, B.F.D. Ghrist. Formulation Development of an Antifibrin Monoclonal Antibody Radiopharmaceutical, M. Kamat, et al. Biophysical Characterization and Formulation of TP40: A Chimeric Protein which Requires a pHdependent Conformational Change for Its Biological Activity, G. Sanyal, et al. Stability Characterization and Formulation Development of Recombinant Human Deoxyribonuclease I [Pulmozyme, (Dornase Alpha)], S.J. Shire. Index.... Mehr